1. Zhao L#, Zhao X, Tian P, Liang L, Huang B, Huang L, Feng J, Zhang Y*, Zhang J*. Prognostic Utility of The Prognostic Nutritional Index Combined with Serum Sodium Level in Patients with Heart Failure. Nutr Metab Cardiovasc Dis. 2022 Aug;32(8):1894-1902. (IF=4.666)
2. Carubelli V#*, Zhang Y#, Metra M, Lombardi C, Felker GM, Filippatos G, O'Connor CM, Teerlink JR, Simmons P, Segal R, Malfatto G, La Rovere MT, Li D, Han X, Yuan Z, Yao Y, Li B, Lau LF, Bianchi G, Zhang J*; Istaroxime ADHF Trial Group. Treatment with 24?Hour Is Taroxime Infusion in Patients Hospitalised for Acute Heart Failure: A Randomised, Placebo-controlled Trial. Eur J Heart Fail. 2020 Sep;22(9):1684-1693. (IF=11.627)
3. Ponnusamy M#, Liu F#, Zhang YH#, Li RB#, Zhai M, Liu F, Zhou LY, Liu CY, Yan KW, Dong YH, Wang M, Qian LL, Shan C, Xu S, Wang Q, Zhang YH, Li PF, Zhang J*, Wang K*. Long non-Noncoding RNA CPR (Cardiomyocyte Proliferation Regulator) Regulates Cardiomyocyte Proliferation and Cardiac Repair. Circulation. 2019 Jun 4;139(23):2668-2684. (IF=23.603, ESI)
4. Zhang Y#, Zhang J#*, Butler J, Yang X, Xie P, Guo D, Wei T, Yu J, Wu Z, Gao Y, Han X, Zhang X, Wen S, Anker SD, Filippatos G, Fonarow GC, Gan T, Zhang R; China-HF Investigators. Contemporary Epidemiology, Management, and Outcomes of Patients Hospitalized for Heart Failure in China: Results From the China Heart Failure (China-HF) Registry. J Card Fail. 2017 Dec;23(12):868-875. (IF=3.987)
5. Wang Y#, Zhang Y*, An T, Zhang R, Zhao X, Liu N, Yin S, Gan T, Liang T, Huang Y, Zhou Q, Zhang J*. ErbB4 Gene Polymorphism Is Associated With the Risk and Prognosis of Congestive Heart Failure in a Northern Han Chinese Population. J Card Fail. 2016 Sep;22(9):700-9. (IF=3.510)
6. Wang K#, Zhou LY, Wang JX, Wang Y, Sun T, Zhao B, Yang YJ, An T, Long B, Li N, Liu CY, Gong Y, Gao JN, Dong YH, Zhang J*, Li PF*. E2F1-dependent miR-421 Regulates Mitochondrial Fragmentation And Myocardial Infarction By Targeting Pink1. Nat Commun. 2015 Jul 17;6:7619. (IF=12.124)
7. Zhang Y#, Zhang R#, An T, Huang Y, Guo X, Yin S, Wang Y, Ji S, Lv R, Zhang J*, Maisel A. The Utility of Galectin-3 For Predicting Cause-specific Death In Hospitalized Patients with Heart Failure. J Card Fail. 2015 Jan;21(1):51-9. (IF=3.583, F1000)
8. Zou CH#, Zhang J*, Zhang YH, Wei BQ, Wu XF, Zhou Q, Huang Y, Zhang RC, Lv R. Frequency And Predictors of Normalization of Left Ventricular Ejection Fraction in Recent-onset Nonischemic Cardiomyopathy. Am J Cardiol. 2014 May 15;113(10):1705-10. (IF=4.089)
9.Li X#*, Zhang J#*, Huang J*, Ma A, Yang J, Li W, Wu Z, Yao C, Zhang Y, Yao W, Zhang B, Gao R; Efficacy and Safety of Qili Qiangxin Capsules for Chronic Heart Failure Study Group. A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of The Effects of Qili Qiangxin Capsules in Patients with Chronic Heart Failure. J Am Coll Cardiol. 2013 Sep 17;62(12):1065-1072. (IF=14.086, C100)
10.Gao R#, Zhang J#, Cheng L#, Wu X, Dong W, Yang X, Li T, Liu X, Xu Y, Li X*, Zhou M*. A Phase II, Randomized, Double-blind, Multicenter, Based on Standard Therapy, Placebo-Controlled Study of The Efficacy and Safety of Recombinant Human Neuregulin-1 in Patients with Chronic Heart Failure. J Am Coll Cardiol. 2010 May 4;55(18):1907-14. (IF=12.640, C100)